Detalhe da pesquisa
1.
Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
Dig Dis Sci
; 61(6): 1744-56, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27059981
2.
Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection.
J Infect Dis
; 209(10): 1602-12, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24325966
3.
Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma.
HPB (Oxford)
; 16(8): 758-67, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24467780
4.
CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury.
J Neurotrauma
; 31(20): 1677-88, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24806994
5.
Impaired lymphocyte reactivity measured by immune function testing in untransplanted patients with cirrhosis.
Clin Vaccine Immunol
; 20(4): 526-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23389930
6.
Nonresponse to interferon-α based treatment for chronic hepatitis C infection is associated with increased hazard of cirrhosis.
PLoS One
; 8(4): e61568, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23637856